BIIB
BIIB
NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$248.35
+4.42 (+1.81%)
As of Nov 7, 9:37 PM ET ·
Analyst Consensus
Buy
44
Analysts
Very High
Coverage
Buy 32 73%
Hold 11 25%
Sell 1 2%
Price Target
Analyst Price Target -63.2% upside
Low Target $57.23
Average Target $91.45
High Target $114.90
Current Price $248.35
Current
$248.35
Target
$91.45
$57.23 $91.45 avg $114.90
Scenario Analysis
Bear Case
$57.23
-77.0%
Low target
Base Case
$91.45
-63.2%
Avg target
Bull Case
$114.90
+-53.7%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$258.78
-4.0% from high
52-Week Low
$148.51
+67.2% from low
50-Day SMA
$230.01
+8.0% vs SMA
200-Day SMA
$203.18
+22.2% vs SMA
RSI (14)
60.2
Neutral
Target vs 52W High
$91.45
-64.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -40.7%